Menu Back to Clinical-Trial-Disclosure-and-Data-Transparency-Conference

Overview

Short Courses: September 18
Conference: September 19-20


Clinical trial information transparency is taking on new dimensions. Clinical trial sponsors and academia are facing a host of new registration requirements in the US and the EU. With evolving requirements comes a host of new challenges, creating additional opportunities for knowledge-sharing and necessitating more interaction with peers. This conference will provide critical and timely information relating to clinical trial disclosure and data transparency from those on the front lines.

NEW! This year's conference will have an even greater global presence than ever!


“A great learning program to receive all updates in this fast-changing and important discipline. A fantastic opportunity to network and meet with key players who are making impact and shaping the community of clinical research.” -2017 Attendee

 


Global Clinical Trial Disclosure and Data Transparency Conference
Call for Poster and Oral Abstracts

Abstract Submission Deadline: Friday, June 28

Read Abstract Details | Submit

Who should attend?

Professionals involved in:
  • Compliance
  • Clinical trial disclosure
  • Transparency policies and compliance
  • Clinical operations
  • Medical writing, medical affairs, and medical communications
  • Regulatory
  • Publications
  • Biometrics
  • Data management
  • Disclosure
  • Data transparency/data sharing

Program Committee

  • Robert  Paarlberg, MS
    Robert Paarlberg, MS Principal
    Paarlberg & Associates LLC, United States
  • Suzanne  Carlson, MA
    Suzanne Carlson, MA Consultant
    ABSD Associates, LLC, United States
  • Kelly  Coulbourne
    Kelly Coulbourne Associate Director, Clinical Trial Data Registries
    Allergan, United States
  • Patrick  Fawcett
    Patrick Fawcett Information Disclosure Administrator
    Office for ClinicalTrials.gov, University of Pittsburgh, United States
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Senior Trial Disclosure Director, Global Clinical Registry
    Novo Nordisk A/S, Denmark, Denmark
  • Francine  Lane, MBA
    Francine Lane, MBA VP, Global Transparency
    TrialScope, United States
  • Nathaniel  Root, MSc
    Nathaniel Root, MSc Associate Director, Disclosure and Transparency
    Ionis Pharmaceuticals, United States
Load More

Contact us

Registration Questions?

Send Email
1.888.257.6457


Global Clinical Trial Disclosure and Data Transparency Conference
Call for Poster and Oral Abstracts

Abstract Submission Deadline: Friday, June 28

Abstract Details | Submit

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download